Watchlist Price Alert

Inhibrx Biosciences Inc. (INBX)

NASDAQ: INBX · Real-Time Price · USD

14.70

-0.21 (-1.41%)

At close: Jun 26, 2025, 3:59 PM

14.79

0.61%

After-hours: Jun 26, 2025, 04:10 PM EDT

Inhibrx Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	152.6M	277.92M	273.87M	131.3M	128.66M	11.54M	2.1M	13.47M	20.02M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	6.83M	3.16M	3.16M	1.85M	245K	245K	1.73M	n/a	n/a
Receivables	420K	778K	257K	878K	615K	438K	690K	696K	n/a
Inventory	n/a	n/a	-257K	-878K	-129.28M	3.21M	2.31M	999K	n/a
Other Current Assets	382K	366K	181K	7.81M	132.17M	376K	553K	276K	383K
Total Current Assets	160.4M	295.36M	280.49M	139.11M	132.17M	15.56M	5.66M	15.44M	20.41M
Property-Plant & Equipment	13.54M	9.37M	7.22M	9.49M	11.32M	10.68M	2.59M	1.8M	864K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	20.37M	12.54M	10.38M	11.34M	11.57M	10.93M	4.33M	1.8M	864K
Total Assets	180.77M	307.89M	290.88M	150.45M	143.74M	26.49M	9.98M	17.25M	21.27M
Account Payables	9.24M	8.31M	4.34M	9.13M	13.46M	3.12M	6.53M	775K	167K
Deferred Revenue	n/a	n/a	166K	2.03M	3.08M	7.94M	1.63M	2.61M	n/a
Short-Term Debt	1.59M	2.06M	1.86M	1.67M	1.5M	4.67M	5.93M	5.17M	4.26M
Other Current Liabilities	22.16M	37.37M	15.97M	9.62M	13.36M	4.85M	2.09M	372K	856K
Total Current Liabilities	40.73M	56.31M	27.58M	22.45M	31.4M	20.57M	16.18M	8.92M	5.28M
Long-Term Debt	6.45M	206.97M	202.07M	70.47M	35.95M	37.06M	3.56M	9.49M	14.66M
Other Long-Term Liabilities	n/a	n/a	n/a	5.14M	180K	61.42M	47.88M	21.25M	92K
Total Long-Term Liabilities	6.45M	208.08M	205.24M	75.61M	36.87M	99.49M	51.45M	30.75M	14.75M
Total Liabilities	47.18M	264.39M	232.82M	98.07M	68.27M	120.06M	67.63M	39.67M	20.03M
Total Debt	8.05M	210.14M	202.07M	70.47M	37.45M	41.73M	9.49M	14.66M	18.92M
Common Stock	1K	5K	4K	4K	4K	2K	3K	n/a	n/a
Retained Earnings	-106.13M	-613.73M	-372.37M	-227.15M	-145.38M	-69.25M	-17.86M	-28.77M	-9.25M
Comprehensive Income	n/a	0.00	n/a	-150.45M	-143.74M	-59.51M	-1.71M	-1.03M	n/a
Shareholders Equity	133.58M	43.5M	58.06M	52.38M	75.47M	-93.57M	-57.64M	-28.77M	-9.25M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a